Azithromycin for respiratory insufficiency

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Apr 2020: Trial registered, NCT04339816
  2. 13 May 2020: Trial started, NCT04339816
  3. 4 Nov 2020: Trial terminated, NCT04339816

The trials

NCT04339816: Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial

State
Stopped early
Phase
Phase 3
People
3 taking part
Started
13 May 2020
Primary completion
4 Nov 2020
Arms
HC-A group
Results
None posted
  1. 9 Apr 2020: Trial registered
  2. 13 May 2020: Trial started
  3. 4 Nov 2020: Trial terminated

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.